Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
Strategic objectives are a foundational component of a medical strategy and are informed by the product and therapeutic landscape – they bridge the gap between where you are now and where you want to be. The objectives ultimately lead to individual tactics and activities that will deliver on the strategy so it is imperative that the objectives are focused, specific and give proper guidance to the medical team and organization. Understanding how to develop robust strategic objectives is a skill that all Medical Affairs teams should possess. This webinar will help you build a foundational knowledge in medical strategy and objective development by covering key topics such as:
1) Consideration of the product and therapeutic landscape
2) Components of robust objectives
3) Importance of collaborative objective development
4) Fundamentals of measuring objectives
Clinical research is typically costly for sponsors and burdensome for providers and patients. New methods and approaches, such as integrated evidence generation using real-world data networks and automated study platforms, are accelerating the path from start-up to read out.
Join presenters as they explore innovative approaches for:
The Alliance and GAME are two of the most important medical education organizations. Combined they host the larger membership between industry, providers and researchers dedicated to develop, implement and measure post-graduate educational programs.
This shared webinar Alliance/GAME/MAPS EE FAWG will:
· Introduce to Medical Affairs non experts the landscape of Medical Education supporting organizations
· Discuss positions and views on different actuality topics (eg. Digital education, Chat GPT/AI, quality education)
Hosted by experienced medical communications experts and industry leaders, this webinar covers how a holistic approach towards a Publication Extender Strategy can elevate the scientific exchange between the industry and HCPs.
Pharmaceutical companies can make information easily accessible and easy to understand with publication extenders, as HCPs are in need of short form, bite-sized information to aid their medical decision making. However, in an age of information overload, a personalized, relevant approach is necessary to reach and engage them effectively.
Current practice is based on one-off, ad-hoc creation of publication extenders, and many important facets of effective communication strategies are often overlooked. The approach presented during this webinar emphasizes the importance of defining clear audience segments, using omnichannel methodology, and learning how to reach a wider audience through a variety of formats.
Participants in this webinar will learn about the benefits of a holistic Publication Extender Strategy and gain practical insights on how to implement one effectively.
Join us for this informative webinar to stay ahead of the curve in the fast-paced world of digital medical communications and learn how to leverage the power of the holistic Publication Extender Strategy to create compelling content and inform, educate, and engage HCPs more effectively.
At the end of the session, you will be able to:
Customer engagements for Medical Affairs has evolved rapidly post COVID-19. Hybrid is the future and that brings with it new challenges, most notably in sustaining engagements with the KOLs to become unbiased scientific partners of choice. As a result, there have been shifts in strategies: newer roles, newer stakeholders to be engaged, and more data and information collected.
There is no one-size-fits-all approach. The intent of this webinar will be to have a discussion on which strategies are working, and how leading companies are defining success for field medical teams in hybrid engagements.
In today’s rapidly evolving pharmaceutical environment, Medical Affairs teams are under increasing pressure to understand how to go beyond “activity engagement” metrics and identify areas of opportunity to advance evidenced-based medicine and treatment with current available data.
This webinar will provide a historical perspective on value, as well as insights to help Medical Affairs professionals measure and demonstrate the impact of their activities in a complex environment.
As Medical Affairs teams strive to identify areas of opportunity and demonstrate their value, understanding the importance of data-driven strategies is essential. In this webinar, we will discuss the historical perspective on value in Medical Affairs, as well as strategies to measure and demonstrate impact in an evolving pharmaceutical environment. Join us to learn more about how data-driven strategies can help you gain a better understanding of your Medical Affairs activities and provide insights into areas of opportunity.
All industries are rushing to harness rich data in order to drive progress, but how can the many data sources help Medical Affairs to show impact and drive improved patient outcomes?
In part three of this four-part series, we will discuss:
This Webinar series explores the fundamental concept of big data in Medical Affairs, from which sources can we retrieve this, what are the broader considerations when utilizing data in health and what impact this can have on our organizations, physicians, and patients, now and in the future. These presentations will feature real-world cases that are relevant to regional and country Medical Affairs leaders, in order to highlight long-term aspirational and short-term tangible projects.
While the value of patient engagement is increasingly recognised in the clinical and launch phases of drug development, it is still a relatively new concept to involve patients in the early discovery phase. By understanding the burden of disease and patient’s aspirations for new treatments from the outset, pharma companies can ensure they are developing medicines that matter to patients. As experts in the disease area and therapeutic landscape, Medical Affairs are well placed to initiate and develop effective patient partnerships to ensure that the patient voice is incorporated during early discovery and beyond.
In this webinar we will explore practical approaches to engaging patients in early development, introducing key resources and discussing best practices. These discussions will be tailored to meet the needs of all Medical Affairs colleagues, regardless of experience.
Medical Affairs professionals want to share Real-World Evidence (RWE) about drug products with payers, patient advocates and others, but communications about drug products are highly regulated. Federal laws, including FDAMA Section 114, FDA guidance materials and FDA enforcement actions all provide insight into the types of communications FDA will and will not accept. This presentation will provide insights into the types of communications that FDA has indicated are or are not permissible, and the uncertainties that still remain.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.